| 2024 | | The Impact of Statins on the Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib or Lenvatinib | 김순선, 노충균, 박범희, 양민재, 은정우, 이길호, 임선교, 정재연, 조효정, 한지은 |
| 2023 | | Circulating small extracellular vesicle-derived splicing factor 3b subunit 4 as a non-invasive diagnostic biomarker of early hepatocellular carcinoma | 김순선, 은정우, 정재연, 조효정 |
| 2023 | | A New Understanding of Long Non-Coding RNA in Hepatocellular Carcinoma—From m6A Modification to Blood Biomarkers | 은정우, 정재연 |
| 2023 | | Tumor Endothelial Cells-Associated Integrin Alpha-6 as a Promising Biomarker for Early Detection and Prognosis of Hepatocellular Carcinoma | 김순선, 은정우, 정재연, 조효정, 한지은 |
| 2023 | | GNAQ-Regulated ZO-1 and ZO-2 Act as Tumor Suppressors by Modulating EMT Potential and Tumor-Repressive Microenvironment in Lung Cancer | 은정우 |
| 2023 | | Cancer-associated fibroblast-derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib | 김석휘, 김순선, 김영배, 은정우, 임수빈, 정재연, 조효정 |
| 2023 | | Aberrantly Expressed MicroRNAs in Cancer-Associated Fibroblasts and Their Target Oncogenic Signatures in Hepatocellular Carcinoma | 김봉완, 김순선, 은정우, 정재연, 조효정, 한지은 |
| 2022 | | 295 (PB075) - Cancer-associated fibroblast-derived SPP1 is a potential target for overcoming sorafenib and lenvatinib resistance in hepatocellular carcinoma | 김순선, 은정우, 정재연, 조효정, 한지은 |
| 2022 | | 258 (PB038) - SORT1 with oncogenic potential associated hypomethylation and promotes tumor progression in hepatocellular carcinoma | 김순선, 은정우, 정재연, 조효정, 한지은 |
| 2022 | | Serum Proteins, HMMR, NXPH4, PITX1 and THBS4; A Panel of Biomarkers for Early Diagnosis of Hepatocellular Carcinoma | 은정우 |
| 2022 | | Risk Prediction Model Based on Magnetic Resonance Elastography-Assessed Liver Stiffness for Predicting Posthepatectomy Liver Failure in Patients with Hepatocellular Carcinoma | 김봉완, 김순선, 김재근, 은정우, 이제희, 정재연, 조효정, 허지미 |
| 2022 | | Novel Gene Signatures as Prognostic Biomarkers for Predicting the Recurrence of Hepatocellular Carcinoma | 김순선, 은정우, 정재연, 조효정 |
| 2022 | | Hypomethylation-mediated upregulation of the WASF2 promoter region correlates with poor clinical outcomes in hepatocellular carcinoma | 강호철, 김순선, 은정우, 정재연, 조효정 |
| 2021 | | Early detection of hepatocellular carcinoma via liquid biopsy: panel of small extracellular vesicle-derived long noncoding RNAs identified as markers | 김순선, 은정우, 정재연, 조효정 |
| 2021 | | Nucleoporin 210 Serves a Key Scaffold for SMARCB1 in Liver Cancer | 은정우 |
| 2021 | | HMBS is the most suitable reference gene for RT-qPCR in human HCC tissues and blood samples | 김순선, 은정우, 정재연, 조효정 |
| 2021 | | Overexpressed proteins in hcc cell-derived exosomes, CCT8, and cofilin-1 are potential biomarkers for patients with HCC | 김순선, 은정우, 정재연, 조효정 |
| 2021 | | Depletion of NK6 Homeobox 3 (NKX6.3) causes gastric carcinogenesis through copy number alterations by inducing impairment of DNA replication and repair regulation | 은정우 |
| 2021 | | Microbiome as a potential diagnostic and predictive biomarker in severe alcoholic hepatitis | 김순선, 은정우, 정재연, 조효정 |
| 2020 | | Serum Exosomal MicroRNA, miR-10b-5p, as a Potential Diagnostic Biomarker for Early-Stage Hepatocellular Carcinoma | 김순선, 은정우, 정재연, 조효정 |
